A biomarker enrichment trial of anti-EGFR agents in right primary tumor location (rPTL), RAS wild-type (RAS-wt) advanced colorectal cancer (aCRC): ARIEL (ISRCTN11061442)

Williams, C, Emmerson, J, Beggs, AD et al. (12 more authors) (2022) A biomarker enrichment trial of anti-EGFR agents in right primary tumor location (rPTL), RAS wild-type (RAS-wt) advanced colorectal cancer (aCRC): ARIEL (ISRCTN11061442). In: Journal of Clinical Oncology. 2022 ASCO Annual Meeting, 03-07 Jun 2022, Online & Chicago, IL, USA. American Society of Clinical Oncology .

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2022 by American Society of Clinical Oncology. Reproduced in accordance with the publisher's self-archiving policy.
Dates:
  • Published (online): 2 June 2022
  • Published: 1 June 2022
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Inst of Clinical Trials Research (LICTR) (Leeds)
Funding Information:
FunderGrant number
NIHR National Inst Health ResearchNIHR 129268
Cancer Research UK Supplier No: 138573A25447
Cancer Research UK Supplier No: 138573C7852/A19772
Cancer Research UK Supplier No: 138573C6003/A7367
Cancer Research UK Supplier No: 138573RCCCTF-Nov21\100001
Depositing User: Symplectic Publications
Date Deposited: 16 Nov 2022 14:34
Last Modified: 10 Jun 2023 00:13
Status: Published
Publisher: American Society of Clinical Oncology
Identification Number: https://doi.org/10.1200/JCO.2022.40.16_suppl.TPS3633

Export

Statistics


CORE (COnnecting REpositories)